Partner with us
Studies
/
Potential therapeutic benefit of exogenous ketone ester administration in delirium: a narrative review
Ketone ester/other
Review
2025

Potential therapeutic benefit of exogenous ketone ester administration in delirium: a narrative review

Key finding
The authors conclude that exogenous ketone esters are a biologically plausible, rapidly acting intervention for delirium in the critically ill that warrants rigorous clinical evaluation, and that randomized controlled trials are essential.
What the study did

This narrative review discusses how exogenous ketone esters might help with delirium in critical illness. It describes altered neurometabolism and neuroinflammation as key features and notes that mechanistic data come mostly from murine models, particularly for sepsis-associated encephalopathy. The authors state that data in the critically ill are limited, but pilot studies suggest enteral ketone supplementation can safely achieve therapeutic serum concentrations without worsening acidosis or hemodynamic instability. They hypothesize that ketone esters may support brain energy production and call for randomized controlled trials to verify safety, optimal dosing and clinical effectiveness.

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.
GOBHB//QUERY_CONSOLE271 STUDIES INDEXED
> Ask what it does, which formats it goes into, or who is already using it.
What does BHB do?goBHB in gummies?Who is using goBHB?
Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ask
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaceutical grade, 48 patents, and over 300 million doses in market.
Ask me about goBHB